These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 22068254

  • 1. Clinical effects of long-term metreleptin treatment in patients with lipodystrophy.
    Chan JL, Lutz K, Cochran E, Huang W, Peters Y, Weyer C, Gorden P.
    Endocr Pract; 2011; 17(6):922-32. PubMed ID: 22068254
    [Abstract] [Full Text] [Related]

  • 2. Effects of Metreleptin in Pediatric Patients With Lipodystrophy.
    Brown RJ, Meehan CA, Cochran E, Rother KI, Kleiner DE, Walter M, Gorden P.
    J Clin Endocrinol Metab; 2017 May 01; 102(5):1511-1519. PubMed ID: 28324110
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy.
    Oral EA, Gorden P, Cochran E, Araújo-Vilar D, Savage DB, Long A, Fine G, Salinardi T, Brown RJ.
    Endocrine; 2019 Jun 01; 64(3):500-511. PubMed ID: 30805888
    [Abstract] [Full Text] [Related]

  • 5. A Report of Three Cases With Acquired Generalized Lipodystrophy With Distinct Autoimmune Conditions Treated With Metreleptin.
    Lebastchi J, Ajluni N, Neidert A, Oral EA.
    J Clin Endocrinol Metab; 2015 Nov 01; 100(11):3967-70. PubMed ID: 26390101
    [Abstract] [Full Text] [Related]

  • 6. Long-term effectiveness and safety of metreleptin in the treatment of patients with generalized lipodystrophy.
    Brown RJ, Oral EA, Cochran E, Araújo-Vilar D, Savage DB, Long A, Fine G, Salinardi T, Gorden P.
    Endocrine; 2018 Jun 01; 60(3):479-489. PubMed ID: 29644599
    [Abstract] [Full Text] [Related]

  • 7. One-year metreleptin improves insulin secretion in patients with diabetes linked to genetic lipodystrophic syndromes.
    Vatier C, Fetita S, Boudou P, Tchankou C, Deville L, Riveline J, Young J, Mathivon L, Travert F, Morin D, Cahen J, Lascols O, Andreelli F, Reznik Y, Mongeois E, Madelaine I, Vantyghem M, Gautier J, Vigouroux C.
    Diabetes Obes Metab; 2016 Jul 01; 18(7):693-7. PubMed ID: 26584826
    [Abstract] [Full Text] [Related]

  • 8. The liver diseases of lipodystrophy: the long-term effect of leptin treatment.
    Safar Zadeh E, Lungu AO, Cochran EK, Brown RJ, Ghany MG, Heller T, Kleiner DE, Gorden P.
    J Hepatol; 2013 Jul 01; 59(1):131-7. PubMed ID: 23439261
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metreleptin Treatment in Patients with Non-HIV Associated Lipodystrophy.
    Akinci G, Akinci B.
    Recent Pat Endocr Metab Immune Drug Discov; 2015 Jul 01; 9(2):74-8. PubMed ID: 26556498
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Leptin decreases de novo lipogenesis in patients with lipodystrophy.
    Baykal AP, Parks EJ, Shamburek R, Syed-Abdul MM, Chacko S, Cochran E, Startzell M, Gharib AM, Ouwerkerk R, Abd-Elmoniem KZ, Walter PJ, Walter M, Muniyappa R, Chung ST, Brown RJ.
    JCI Insight; 2020 Jul 23; 5(14):. PubMed ID: 32573497
    [Abstract] [Full Text] [Related]

  • 14. Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy.
    Nagayama A, Ashida K, Watanabe M, Moritaka K, Sonezaki A, Kitajima Y, Takahashi H, Yoshinobu S, Iwata S, Yasuda J, Hasuzawa N, Ozono S, Motomura S, Nomura M.
    Front Endocrinol (Lausanne); 2021 Jul 23; 12():690996. PubMed ID: 34135866
    [Abstract] [Full Text] [Related]

  • 15. Long-term efficacy of leptin replacement in patients with generalized lipodystrophy.
    Javor ED, Cochran EK, Musso C, Young JR, Depaoli AM, Gorden P.
    Diabetes; 2005 Jul 23; 54(7):1994-2002. PubMed ID: 15983199
    [Abstract] [Full Text] [Related]

  • 16. Recombinant human leptin treatment in genetic lipodystrophic syndromes: the long-term Spanish experience.
    Araujo-Vilar D, Sánchez-Iglesias S, Guillín-Amarelle C, Castro A, Lage M, Pazos M, Rial JM, Blasco J, Guillén-Navarro E, Domingo-Jiménez R, del Campo MR, González-Méndez B, Casanueva FF.
    Endocrine; 2015 May 23; 49(1):139-47. PubMed ID: 25367549
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity associated with metreleptin treatment in patients with obesity or lipodystrophy.
    Chan JL, Koda J, Heilig JS, Cochran EK, Gorden P, Oral EA, Brown RJ.
    Clin Endocrinol (Oxf); 2016 Jul 23; 85(1):137-49. PubMed ID: 26589105
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Metreleptin for injection to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy.
    Meehan CA, Cochran E, Kassai A, Brown RJ, Gorden P.
    Expert Rev Clin Pharmacol; 2016 Jul 23; 9(1):59-68. PubMed ID: 26465174
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.